Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients

This study was conducted to evaluate de novo donor-specific anti-human leukocyte antigen (HLA) antibody (dnDSA) production leading to antibody-mediated rejection (ABMR) after rituximab induction in non-sensitized ABO-compatible living kidney transplantation (ABO-CLKTx). During 2008–2015, 318 ABO-CLK...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Yusuke, Iwadoh, Kazuhiro, Ogawa, Yuichi, Miki, Katsuyuki, Kato, Yojiro, Kai, Kotaro, Sannomiya, Akihito, Koyama, Ichiro, Kitajima, Kumiko, Nakajima, Ichiro, Fuchinoue, Shohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808551/
https://www.ncbi.nlm.nih.gov/pubmed/31644555
http://dx.doi.org/10.1371/journal.pone.0224203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808551/
https://www.ncbi.nlm.nih.gov/pubmed/31644555
http://dx.doi.org/10.1371/journal.pone.0224203

Ejemplares similares